SCHEMBL21687707

SCHEMBL21687707

N#Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c(-c2cccc(-n3c4ccc(C#N)cc4c4cc(C#N)ccc43)c2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 3/20 0.35
G6PD P11413 1/20 0.34
CYP19A1 P11511 1/20 0.34
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
ALDH1A1 P00352 3/20 0.33
GRM5 P41594 1/20 0.33
GABRA2 P47869 1/20 0.33
METAP2 P50579 1/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
MCL1 Q07820 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687687 0.97 KDM4E (0.35) TDP2G6PDCYP19A1GABRA1GABRG2
SCHEMBL21687702 0.93 TDP2 (0.35) TDP2G6PDGABRA1GABRG2GABRB3
SCHEMBL21687458 0.93 KDM4E (0.38) TDP2CYP19A1ALDH1A1GRM5METAP2
SCHEMBL21687839 0.91 TDP2 (0.34) TDP2G6PDGABRA1GABRG2GABRB3
SCHEMBL21688004 0.91 TDP2 (0.35) TDP2G6PDCYP19A1ALDH1A1GRM5
SCHEMBL21687989 0.90 KDM4E (0.35) TDP2G6PDGABRA1GABRG2GABRB3
SCHEMBL21687463 0.90 ADRA2C (0.34) TDP2G6PDALDH1A1GRM5HSD17B10
SCHEMBL21687667 0.88 CYP19A1 (0.35) TDP2G6PDCYP19A1GABRA1GABRG2
SCHEMBL21687709 0.88 CNR2 (0.35) TDP2G6PDALDH1A1HSD17B10KDM4E
SCHEMBL21688006 0.88 TDP2 (0.34) TDP2G6PDGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 TDP2 4123/4885G6PD 3421/4885CYP19A1 87/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 TDP2 4123/4885G6PD 3421/4885CYP19A1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.